Related by context. Frequent words. (Click for all words.) 70 limiting toxicity 67 pharmacokinetics PK 67 efficacy tolerability 67 Tolerability 66 tumor lysis syndrome 65 refractory chronic lymphocytic 65 pharmacodynamic effects 64 tolerated dose MTD 64 dose limiting toxicities 64 Initiate Phase 64 Pharmacokinetic 63 Well Tolerated 63 nab paclitaxel 63 neutropenia thrombocytopenia 63 Pivotal Phase III 63 plus prednisone 63 Panzem R 63 ganetespib 62 elotuzumab 62 pharmacokinetic parameters 62 forodesine 62 Immunogenicity 62 phase Ib 62 Coadministration 62 hypercalcemia 62 DOXIL 62 administered subcutaneously 62 Single Dose 62 Secondary endpoints include 61 DAVANAT 61 pharmacokinetic PK 61 heparin induced thrombocytopenia 61 analgesic efficacy 61 II Clinical Trial 61 PREZISTA r 61 Secondary endpoints included 61 Phase 1b trial 61 liposomal formulation 61 Epratuzumab 61 rNAPc2 61 R sorafenib tablets 61 Pivotal Phase 61 Completes Enrollment 60 ixabepilone 60 SCH # 60 KRN# 60 Drug Candidate 60 mycophenolate mofetil 60 primary hypercholesterolemia 60 Phase III Clinical Trial 60 pertuzumab 60 Engerix B 60 Clinical Trial Results 60 6R BH4 60 mcg kg 60 peginterferon alfa 60 GSK# [001] 60 Dapagliflozin 60 Pegasys ® 60 Navelbine 60 Phase III Trial 60 Phase Ib II 60 romidepsin 60 vomiting CINV 59 safety tolerability pharmacokinetics 59 Presents Positive 59 Entereg R 59 Eltrombopag 59 QTc prolongation 59 tigecycline 59 tipranavir 59 Dasatinib 59 FDA Accepts 59 AVANDIA 59 Microplasmin 59 PEG SN# 59 INC# 59 long acting beta2 59 BrachySil 59 intravenously administered 59 thromboembolic events 59 ThermoDox R 59 Cloretazine R VNP#M 59 AVE# 59 renal toxicity 59 Lacosamide 59 Gemzar ® 59 NVA# 59 Vandetanib 59 Adalimumab 59 Capecitabine 59 metastatic castration resistant 59 LCP Tacro 59 pseudobulbar affect PBA 59 ISTODAX 59 edoxaban 59 tolerability 59 lixisenatide 59 Recombinant Human 59 MAP# 59 Metastatic Melanoma